3623 results for «73»

Filter By

3623 results

Which techniques for the treatment of left main lesions ?

20 May 2025 – From EuroPCR 2025

This session reviews advanced techniques for treating left main coronary artery lesions. Learn about precise stent positioning, T-modified bifurcation techniques, CHIP PCI approaches, proximal optimisation, and the innovative RODIN-CUT technique to optimize procedural success.

Which techniques for the treatment of left main lesions ?

How to handle the most clinically relevant challenges in TAVI

21 May 2025 – From EuroPCR 2025

This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...

How to handle the most clinically relevant challenges in TAVI

Impact of transcatheter mitral valve treatment on ventricular dimensions and functions

20 May 2025 – From EuroPCR 2025

Investigate the impact of transcatheter mitral valve therapies on ventricular dimensions and function. This session discusses invasive physiology changes, left and right ventricular remodeling post-TEER and TMVR, and geometric alterations of the mitral annulus, presenting data from multiple registries and studies.

Impact of transcatheter mitral valve treatment on ventricular dimensions and functions

How to optimise TAVI outcomes in the Asian-Pacific population?

22 May 2025 – From EuroPCR 2025

What are the key considerations for TAVI in Asian-Pacific patients? This EuroPCR 2025 session focuses on optimising outcomes in anatomically and clinically specific contexts, such as patients with small annuli. Learn how the latest intra-annular self-expanding devices can help reduce post-procedural pacemaker implantation (PPI) rates, and...

How to optimise TAVI outcomes in the Asian-Pacific population?

The rise of intracoronary imaging: current use and new tools

20 May 2025 – From EuroPCR 2025

Discover advances in intracoronary imaging including frequency of use, stent optimization benefits, and new technologies such as high-frequency saline OCT and deep learning plaque assessment. This session highlights clinical applications and innovative tools enhancing imaging quality and diagnostic accuracy.

The rise of intracoronary imaging: current use and new tools

If I can’t stent it, should I care? Unmasking hidden atherosclerosis through novel imaging techniques

22 May 2025 – From EuroPCR 2025

Unveil the potential of novel imaging techniques in identifying hidden atherosclerosis and silent inflammation. This session discusses the role of perivascular adipose tissue in plaque development, highlights advances in early inflammation detection, and explores clinical management of patients with athero-inflammation beyond traditional stenting options.

If I can’t stent it, should I care? Unmasking hidden atherosclerosis through novel imaging techniques

Innovations in TMVR and Intrepid trial updates

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...

Innovations in TMVR and Intrepid trial updates

What is new in radial access in 2025

20 May 2025 – From EuroPCR 2025

Explore the latest developments in radial access for PCI as of 2025. Topics include distal versus conventional transradial access, techniques to reduce forearm complications, sheathless approaches, dual artery compression methods, and feasibility in high bleeding risk patients.

What is new in radial access in 2025

Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS

21 May 2025 – From EuroPCR 2025

Unlock cutting-edge strategies for thrombus removal in acute coronary syndrome (ACS) with this EuroPCR 2025 session. Understand the mechanisms behind microvascular obstruction and no-reflow phenomena, and why effective thrombus management is crucial. Review the latest clinical evidence, from the Cheetah study to the ongoing TACTIC randomised...

Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS

Challenging scenarios in acute coronary syndrome

20 May 2025 – From EuroPCR 2025

This session presents challenging acute coronary syndrome (ACS) cases with unusual presentations and complications. Learn from cases involving myocarditis mimics, coronary aneurysms, rescue fibrinolysis during PCI, and STEMI complicated by cardiogenic shock, highlighting diagnostic and therapeutic nuances.

Challenging scenarios in acute coronary syndrome

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights how imaging can drive precision in modern PCI. From CT-guided planning to IVUS-guided drug-eluting balloon interventions, each presentation offers practical insights into optimising patient outcomes. Step-by-step approaches and recorded cases illustrate how to tailor tool and technique selection, while also addressing...

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

Key principles of successful large bore vascular access and closure: TAVI and beyond

21 May 2025 – From EuroPCR 2025

This session explores suture-mediated vascular closure techniques, particularly for TAVI and large-bore venous access.  

Through real-world clinical case, speakers highlight the value of ultrasound and CT imaging for precise puncture planning and complication avoidance.  

Detailed steps for arterial closure with ProGlide device are provided, with technical...

Key principles of successful large bore vascular access and closure: TAVI and beyond

DCB in de novo lesions: new valid option?

20 May 2025 – From EuroPCR 2025

Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.

DCB in de novo lesions: new valid option?

Key procedural factors in pulmonary embolism treatment with computer-assisted vacuum thrombectomy

20 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session on pulmonary embolism to explore the role of computer-assisted vacuum thrombectomy (CAVT) as an alternative to medical treatment in high-risk (massive) PE, supported by insights from the STRIKE PE study. Discover how CAVT rapidly and effectively offloads the right ventricle in intermediate-high-risk...

Key procedural factors in pulmonary embolism treatment with computer-assisted vacuum thrombectomy

Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights the latest device innovations reshaping interventional cardiology. Learn how the Myval OCTAPRO THV combines predictable deployment with minimal foreshortening for improved outcomes in structural heart procedures. In the coronary space, the session explores the renewed appeal of the “leave nothing behind”...

Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary

Simplify PCI! Know where and how to win with drug-coated balloon

22 May 2025 – From EuroPCR 2025

This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...

Simplify PCI! Know where and how to win with drug-coated balloon

Transcatheter management of structural defects

20 May 2025 – From EuroPCR 2025

Explore the transcatheter management of structural cardiac defects with challenging clinical scenarios including ventricular septal ruptures and post-TAVI complications. This session emphasizes multidisciplinary approaches and strategic planning to avert catastrophic outcomes and optimize patient care.

Transcatheter management of structural defects

Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...

Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

22 May 2025 – From EuroPCR 2025

This session covers the latest best practices and technologies for large hole arterial and venous closure, focusing on minimising vascular complications.

Learn about a novel patch-based closure system with encouraging early results in TAVI cases, highlighting the importance of deployment angle and ultrasound guidance.

The venous case presentation...

Successful finale - Latest best practices and technologies for large hole arterial and venous closure

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
Didn’t find what you were looking for?